Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Sep-Oct;13(5):1100-11.
doi: 10.1021/bc020025i.

Functionalized congeners of tyrosine-based P2X(7) receptor antagonists: probing multiple sites for linking and dimerization

Affiliations

Functionalized congeners of tyrosine-based P2X(7) receptor antagonists: probing multiple sites for linking and dimerization

Wangzhong Chen et al. Bioconjug Chem. 2002 Sep-Oct.

Abstract

Chemically funtionalized analogues of antagonists of the P2X(7) receptor, an ATP-gated cation channel, were synthesized as tools for biophysical studies of the receptor. These functionalized congeners were intended for use in chemical conjugation with retention of biological potency. The antagonists were L-tyrosine derivatives, related to [N-benzyloxycarbonyl-O-(4-arylsulfonyl)-L-tyrosyl]benzoylpiperazine (such as MRS2409, 2). The analogues were demonstrated to be antagonists in an assay of human P2X(7) receptor function, consisting of inhibition of ATP-induced K(+) efflux in HEK293 cells expressing the recombinant receptor. The analogues were of the general structure R(1)-Tyr(OR(2))-piperazinyl-R(3), in which three positions (R(1)-R(3)) were systematically varied in structure through introduction of chemically reactive groups. Each of the three positions was designed to incorporate a 3- or 4-nitrophenyl group. The nitro groups were reduced using NaBH(4)-copper(II) acetylacetonate to amines, which were either converted to the isothiocyanate groups, as potential affinity labels for the receptor, or acylated, as models for conjugation. An alternate route to N(alpha)-3-aminobenzyloxycarbonyl functionalization was devised. The various positions of functionalization were compared for effects on biological potency, and the R(2) and R(3) positions were found to be most amenable to derivatization with retention of high potency. Four dimeric permutations of the antagonists were synthesized by coupling each of the isothiocyanate derivatives to either the precursor amine or to other amine congeners. Only dimers linked at the R(2)-position were potent antagonists. In concentration-response studies, two derivatives, a 3-nitrobenzyloxycarbonyl derivative 18 and a 4-nitrotoluenesulfonate 26b, displayed IC(50) values of roughly 100 nM as antagonists of P2X(7) receptor-mediated K(+) flux.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effects of tyrosyl derivatives on P2X7 receptor-activation in hP2X7–HEK cells. Cells were preincubated with or without the indicated concentrations of selected antagonists (26b MRS2447; 32 MRS2452; 18 MRS2464; and 30 MRS2483) prior to stimulation with 3 mM ATP. Data points represent the mean (± SD) K+ contents from triplicate wells in a single experiment. IC50 values mentioned in the text are rough estimates from visual inspection of the concentration–response relationships. Hill coefficients were not determined, since previous studies have shown that the lead compound (KN-62) represses P2X7 receptor function via complex mechanisms that are not readily amenable to standard ligand-binding analyses.
Scheme 1
Scheme 1
Synthesis of P2X7 Receptor Antagonists Consisting of L-Tyrosine Derivatives Differing in the Cinnamoyl or Urethane Substituent Present at the Nα Position
Scheme 2
Scheme 2
Synthesis of P2X7 Receptor Antagonists Consisting of L-Tyrosine Derivatives Containing a Nitro Substitution at Either the Nα-Cinnamoyl Substituent, the Aryl Sulfonate Group Present on the Tyrosyl Side Chain, or the Cα-Benzoylpiperazine Substituent
Scheme 3
Scheme 3
Synthesis of P2X7 Receptor Antagonists Consisting of L-Tyrosine Derivatives Containing a Nitro Substitution at the Nα-Benzyloxycarbonyl Substituent or of the Cα-Benzoylpiperazine Substituent
Scheme 4
Scheme 4
Synthesis of P2X7 Receptor Antagonists Consisting of L-Tyrosine Derivatives Containing a Nitro Substitution at the Aryl Sulfonate Group Present on the Tyrosyl Side Chain
Scheme 5
Scheme 5
Synthesis of P2X7 Receptor Antagonists Consisting of L-Tyrosine Derivatives Containing 3-Nitro Substitution at the Nα-Benzyloxycarbonyl Substituent
Scheme 6
Scheme 6
Functional Group Replacement in P2X7 Receptor Antagonists
Scheme 7
Scheme 7
Dimerization of P2X7 Receptor Antagonists through Formation of Thiourea Linkages

References

    1. Fredholm BB, Abbracchio MP, Burnstock G, Dubyak GR, Harden TK, Jacobson KA, Schwabe U, Williams M. Toward a revised nomenclature for P1 and P2 receptors. Trends Pharm Sci. 1997;18:79–82. - PMC - PubMed
    1. Khakh BS, Burnstock G, Kennedy C, King BF, North RA, Seguela P, Voigt M, Humphrey PP. International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev. 2001;53:107–118. - PubMed
    1. King BF. Cardiovascular Biology of Purines. Kluwer Academic Publishers; Norwell, MA: 1998. pp. 159–186. Ch. 10.
    1. Collo G, Neidhart S, Kawashima E, Kosco-Vilbois M, North RA, Buell G. Tissue distribution of the P2 × 7 receptor. Neuropharmacology. 1997;36:1277–1283. - PubMed
    1. Ferrari D, Stroh C, Schulze-Osthoff K. P2X7/P2Z purinoreceptor-mediated activation of transcription factor NFAT in microglial cells. J Biol Chem. 1999;274:13205–13210. - PubMed

Publication types